AKT1 and Cognitive impairment: For example, intracerebral injection of rats with U18666A for 14–21 days led to decreased cholesterol and increased desmosterol, amyloid beta accumulation, decreased neuron-specific enolase, decreased p-Akt and p-GSK-3beta, and Morris water maze cognitive impairment [90].